ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Geriatric Medicine

Top Geriatric Medicine Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARLETHA ANDERSON M.D.

Geriatric Medicine

27,920

$1.63M

586
442 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

33%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $53

SRINIVASA MADIREDDY M.D

Geriatric Medicine

23,465

$1.33M

576
500 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

29%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $53

MARK JACKSON MD

Geriatric Medicine

22,330

$1.04M

535
505 are 65+

32%
patients receiving schedule two controlled substances

Avg: 14%

27%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $53

RAYMOND TRACY D.O.

Geriatric Medicine

21,065

$1.16M

635
495 are 65+

16%
patients receiving schedule two controlled substances

Avg: 14%

28%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $53

WILLIAM KERR MD

Geriatric Medicine

19,943

$1.07M

354
308 are 65+

29%
patients receiving schedule two controlled substances

Avg: 14%

27%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $53

CYNTHIA OCHS DO

Geriatric Medicine

18,539

$962K

577
535 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

22%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $53

CHRISTOPHER POGLIANO MD

Geriatric Medicine

17,637

$798K

353
323 are 65+

24%
patients receiving schedule two controlled substances

Avg: 14%

19%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $53

JAY KLEIN DO

Geriatric Medicine

15,825

$990K

356
301 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

29%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $53

RONALD DUEMLER MD

Geriatric Medicine

13,304

$564K

452
442 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $53

JANET SUTTON D.O.

Geriatric Medicine

10,104

$429K

383
341 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $53

MARCEL ELANJIAN D.O.

Geriatric Medicine

9,920

$524K

246
148 are 65+

27%
patients receiving schedule two controlled substances

Avg: 14%

39%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $53

ASAD RAZA MD

Geriatric Medicine

9,725

$472K

505
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

44%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $53

SHANNON ENGLISH MD

Geriatric Medicine

8,750

$445K

283
279 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $53

MARTIN JENNINGS DO

Geriatric Medicine

7,931

$489K

243
193 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

26%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $53

DANIEL SMALLEY DO

Geriatric Medicine

7,346

$353K

176
166 are 65+

16%
patients receiving schedule two controlled substances

Avg: 14%

28%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $53

ABDUL HAQ MD

Geriatric Medicine

7,180

$514K

298
99 are 65+

67%
patients receiving schedule two controlled substances

Avg: 14%

47%
patients receiving schedule three controlled substances

Avg: 25%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $53

HOMA HASNAIN M.D.

Geriatric Medicine

6,644

$291K

145
123 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

32%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $53

GARY WOZNIAK M.D.

Geriatric Medicine

6,455

$303K

469
394 are 65+

3%
patients receiving schedule two controlled substances

Avg: 14%

17%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $53

FRANCIS KOMARA D.O.

Geriatric Medicine

6,294

$390K

169
162 are 65+

21%
patients receiving schedule two controlled substances

Avg: 14%

21%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $53

PURUSHOTTAM NAIK M.D.

Geriatric Medicine

6,111

$322K

240
217 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

25%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $53

DOUGLAS KRAUSE M.D.

Geriatric Medicine

6,015

$307K

320
229 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $53

MARK ENSBERG MD

Geriatric Medicine

5,943

$357K

253
243 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

23%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $53

E. BYRUM PATRICK M.D.

Geriatric Medicine

5,567

$253K

357
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

24%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $53

EDWARD LEAN MD

Geriatric Medicine

5,448

$267K

187
169 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

25%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

MICHAEL SMITH MD

Geriatric Medicine

4,855

$236K

100
82 are 65+

22%
patients receiving schedule two controlled substances

Avg: 14%

22%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank